zolbetuximab
astellas
[]
spotlight trial of #zolbetuximab + mfolfox6 improved progression-free and overall survival in patients with cldn18.2+, her2- locally advanced unresectable or metastatic gastric/#gej adenocarcinoma. #gicsm #gi23 | 
Oncology news and insights from leading researchers and cancer centers.